Crossmark

Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases

Published Online: 2021-04-17

Published Print: 2021-06

Authors

Chakraborty, Debdulal https://orcid.org/0000-0001-9693-7882
Stewart, Michael W.

Sheth, Jay U.

Sinha, Tushar K.

Boral, Subhendu

Das, Arnab

Mondal, Soumen

Mukherjee, Angshuman
License Information

Text and Data Mining valid from 2021-04-17

Version of Record valid from 2021-04-17
More Information

Article History

Received: 3 March 2021

Accepted: 30 March 2021

First Online: 17 April 2021

Document is current